MEDVi QUAD is MEDVi’s compounded sublingual ED SKU. Viagra is Pfizer’s brand of sildenafil; generics are widely sold. This comparison is for men trying to decide whether a combo liquid is worth more than a labeled tablet.
Is It Better than Viagra?
Not in the FDA-approval sense. Sildenafil tablets have finished-drug approval for ED. QUAD has a sildenafil component plus tadalafil, PT-141, and L-citrulline without combination approval. “Better” can only mean better for your goals after a clinician weighs extra ingredients, extra cost, and extra uncertainty.
| Dimension | Viagra / generic sildenafil | MEDVi QUAD |
|---|---|---|
| Regulatory status | Approved finished drug at labeled doses | Compounded combo, not approved as a finished 4-in-1 |
| Ingredients | Sildenafil only | Sildenafil + tadalafil + PT-141 + L-citrulline (July 2026 brand list) |
| Onset (typical labeled / marketed) | Often about 30–60 minutes for tablets; food can delay | Ads cite 10–15 minutes sublingual; not a combo trial |
| Duration | About 4 hours class discussion for sildenafil | Tadalafil in the mix is why 36-hour talk appears; unproven for the combo |
| 2026 cash cost | Generic can be low per tablet | About $114–$179 per month brand-stated kits |
vs Cialis · alternatives · review
Sources Checked for This Page
- FDA warning letter MEDVi, LLC dba MEDVi, 721455, 20 February 2026.
- FDA product labels for sildenafil, tadalafil, and bremelanotide (Vyleesi).
- Brand-facing MEDVi pages and 2026 secondary reporting on the QUAD formula and list prices.
Individual ingredients such as sildenafil and tadalafil are FDA-approved for other indications; the combined compounded formulation has not been evaluated by the FDA as a finished product, standard for all compounded medicines.